|
||||||||||||||||||
|
|
||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq. DescriptionThe No. 72-1 monoclonal antibody reacts with mouse CD36, which is a 88 kDa member of the class B scavenger receptor family. Murine CD36 was discovered using an expression cloning strategy to identify macrophage receptors that recognized oxidized low-density lipoprotein (oxLDL), but not acetylated low-density lipoprotein (LDL). CD36 is a platelet-membrane glycoprotein, but is also expressed on monocytes/macrophages, granulocytes, B lymphocytes, microvascular endothelial cells, adipocytes, skeletal muscle and dendritic cells. The role of CD36 as a scavenger receptor was confirmed by the CD36-deficient mouse, which was defective in the binding and uptake of oxLDL by peritoneal macrophages. In addition to binding oxLDL, CD36 binds other ligands including TSP-1, anionic phospholipids, apoptotic cells, collagen, Plasmodium falciparum-infected erythrocytes and long-chain fatty acids. Testing also shows staining on some B cells in the bone marrow in addition to the myeloid cells. For more information, please contact tech@ebioscience.com . Applications ReportedFor research use only, not for diagnostic or therapeutic use. This No.72-1 antibody has been reported for use in flow cytometric analysis. Applications TestedThis No.72-1 antibody has been tested by flow cytometric analysis of J7441.1 cells. This can be used at less than or equal to 0.25 μg per million cells in a 100 μl total staining volume. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest. Direct conjugates are recommended for flow cytometric studies. References
Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 1993 Jun 5;268(16):11811-6. Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, Hoff HF, Sharma K, Silverstein RL. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest. 2000 Apr;105(8):1049-56. Zhang P, Li W, Wang Y, Hou L, Xing Y, Qin H, Wang J, Liang Y, Han H. Identification of CD36 as a new surface marker of marginal zone B cells by transcriptomic analysis. Mol Immunol. 2007 Jan;44(4):332-7. Related ProductsCat. 11-4317 Streptavidin-FITC (Fluorescein isothiocyanate) Cat. 12-4317 Streptavidin-PE (Phycoerythrin) Cat. 17-4317 Streptavidin Allophycocyanin (SA-APC) Cat. 14-4321 Affinity Purified Rat IgG2a Isotype Control Cat. 11-4811 FITC Anti-Rat IgG Cat. 13-4813 Biotin Anti-Rat IgG (clone Polyclonal) |
|||||||||||||||||||||||||||||||||||||||||||||
![]() |
![]() |
|
Copyright © 2000-2008 eBioscience, Inc. Product For Research Use Only: Not for further distribution without written consent. |